Cronos Group Inc (NASDAQ:CRON)

14.90
Delayed Data
As of Jan 18
 +1.24 / +9.08%
Today’s Change
4.75
Today|||52-Week Range
15.30
+43.41%
Year-to-Date
Cronos Group (CRON) Catches Eye: Stock Jumps 9.1%
9:12am / Zacks.com - Paid Partner Content
Tilray Shares Rally as Investor Plans Not to Sell Shares
Jan 14 / Zacks.com - Paid Partner Content
Cronos Group (CRON) Outpaces Stock Market Gains: What You Should Know
Jan 17 / Zacks.com - Paid Partner Content
Can Altria's Expansion in RRPs & Cannabis Enable a Revival?
Jan 10 / Zacks.com - Paid Partner Content
Zacks Investment Ideas feature highlights: Tilray, Canopy and Cronos
Jan 17 / Zacks.com - Paid Partner Content
Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know
Jan 08 / Zacks.com - Paid Partner Content
Why Marijuana ETF is on a High in 2019
Jan 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close13.66
Today’s open13.97
Day’s range13.94 - 15.19
Volume23,020,837
Average volume (3 months)13,638,470
Market cap$1.5B
Data as of 4:00pm ET, 01/18/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+608.57%
P/E ratioNM
Price/Sales437.01
Price/Book18.48

Competitors

 Today’s
change
Today’s
% change
APHAAphria Inc+0.20+3.09%
LJPCLa Jolla Pharmaceuti...+0.05+0.80%
CTSOCytosorbents Corp+0.08+1.05%
CDXCChromadex Corp-0.02-0.60%
Data as of 4:02pm ET, 01/18/2019

Financials

Next reporting dateFebruary 27, 2019
EPS forecast (this quarter)$0.00
Annual revenue (last year)$3.1M
Annual profit (last year)$1.9M
Net profit margin61.02%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Michael Gorenstein
Chief Operating Officer
David Hsu
Corporate headquarters
Toronto, Ontario

Forecasts